0001193125-23-199181.txt : 20230731 0001193125-23-199181.hdr.sgml : 20230731 20230731163952 ACCESSION NUMBER: 0001193125-23-199181 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20230731 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20230731 DATE AS OF CHANGE: 20230731 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Addus HomeCare Corp CENTRAL INDEX KEY: 0001468328 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082] IRS NUMBER: 205340172 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34504 FILM NUMBER: 231127872 BUSINESS ADDRESS: STREET 1: 6303 COWBOYS WAY STREET 2: SUITE 600 CITY: FRISCO STATE: TX ZIP: 75034 BUSINESS PHONE: 469-535-8200 MAIL ADDRESS: STREET 1: 6303 COWBOYS WAY STREET 2: SUITE 600 CITY: FRISCO STATE: TX ZIP: 75034 8-K 1 d501240d8k.htm 8-K 8-K
Addus HomeCare Corp false 0001468328 0001468328 2023-07-31 2023-07-31

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): July 31, 2023

 

 

ADDUS HOMECARE CORPORATION

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-34504   20-5340172

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

6303 Cowboys Way, Suite 600

Frisco, Texas

  75034
(Address of principal executive offices)   (Zip Code)

(469) 535-8200

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

 

 

Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d- 2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e- 4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange

on which registered

Common Stock, $0.001 par value per share   ADUS   The Nasdaq Stock Market, LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company.  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 2.02

Results of Operations and Financial Condition.

On July 31, 2023, Addus HomeCare Corporation (the “Company”) issued a press release (the “Press Release”) announcing, among other matters, the Company’s results of operations for the fiscal quarter ended June 30, 2023. A copy of the Press Release is furnished herewith as Exhibit 99.1 to this report and is incorporated herein by reference.

 

Item 7.01.

Regulation FD Disclosure

On July 31, 2023, the Company issued the Press Release, announcing, among other matters, its results of operations for the fiscal quarter ended June 30, 2023, the text of which is set forth as Exhibit 99.1.

 

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits:

 

Exhibit

No.

   Description
99.1    Press Release of Addus HomeCare Corporation dated July 31, 2023.
104    Cover Page Interactive Data File (embedded within Inline XBRL document).


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    ADDUS HOMECARE CORPORATION
Date: July 31, 2023     By:  

/s/ Brian Poff

      Brian Poff
      Chief Financial Officer
EX-99.1 2 d501240dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO

 

Contacts:   
Brian W. Poff    Dru Anderson
Executive Vice President, Chief Financial Officer    FINN Partners
Addus HomeCare Corporation    (615) 324-7346
(469) 535-8200    dru.anderson@finnpartners.com
investorrelations@addus.com   

ADDUS HOMECARE ANNOUNCES SECOND QUARTER 2023 FINANCIAL RESULTS

Frisco, Texas (July 31, 2023) – Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announced its financial results for the second quarter ended June 30, 2023.

Second Quarter 2023 Highlights:

 

   

Net Service Revenues Grow 9.7% to $260.0 Million

 

   

Net Income of $14.9 Million, or $0.91 per Diluted Share

 

   

Adjusted Net Income per Diluted Share Increases 17.6% year-over-year to $1.07

 

   

Adjusted EBITDA Increases year-over-year 12.7% to $28.3 Million

 

   

Cash Flow from Operations of $41.6 Million

 

   

Announced a definitive agreement to acquire the home health, hospice and private duty nursing operations of Tennessee Quality Care, which services patients in over 50 counties in Tennessee.

Overview

Net service revenues were $260.0 million for the second quarter of 2023, a 9.7% increase compared with $236.9 million for the second quarter of 2022. Net income was $14.9 million for the second quarter of 2023, compared with $11.3 million for the second quarter of 2022, while net income per diluted share was $0.91 compared with $0.70 for the same period a year ago. Adjusted EBITDA increased 12.7% to $28.3 million for the second quarter of 2023 from $25.1 million for the second quarter of 2022. Adjusted net income was $17.4 million for the second quarter of 2023 compared with $14.7 million for the prior-year period, while adjusted net income per diluted share was $1.07 compared with $0.91 for the second quarter of 2022. Adjusted net income per diluted share for the second quarter of 2023 excludes the impact of retroactive New York rate increase of $(0.05), acquisition expenses of $0.08 and stock-based compensation expense of $0.13 (See the end of press release for a reconciliation of all non-GAAP and GAAP financial measures.)

For the first six months of 2023, net service revenues increased 10.4% to $511.6 million from $463.6 million for the prior-year period. Net income was $27.5 million for the first six months of 2023 compared with $19.7 million for the same period in 2022, and net income per diluted share was $1.69 compared with $1.22 per diluted share. Adjusted EBITDA increased 14.8% to $54.6 million for the first six months of 2023 from $47.5 million for the first six months of 2022. Adjusted net income was $33.4 million for the first six months of 2023 compared with $27.1 million for the first six months of 2022, while adjusted net income per diluted share was $2.05 compared with $1.68 for the prior-year period.

Commenting on the results, Dirk Allison, Chairman and Chief Executive Officer, said, “Addus delivered a very strong financial and operating performance for the second quarter of 2023, highlighted by 9.7% top line growth in overall revenues and 12.7% growth in Adjusted EBITDA compared to the second quarter of 2022. Our strong volume trends in personal care, our largest segment, were a significant driver of our growth for the quarter. Demand for our personal care services continues to grow, reflecting a greater awareness of the value of home-based care as the preferred and most cost-effective option for many individuals. Our team has done an outstanding job in meeting this demand as we continue to provide safe, high-quality care for our patients in the home, while delivering consistent financial results. We expect to see gradual improvement and expansion opportunities in our home health and hospice operations in the second half of 2023 as the clinical staffing environment continues to improve and as a result of the expiration of the public health emergency. With our balance sheet and strong cash flow, we are well positioned to leverage our scale and expertise and extend our market coverage in all three levels of care.

 

-MORE-


ADUS Announces Second Quarter 2023 Financial Results

Page 2

July 31, 2023

 

“For our personal care segment, we achieved an impressive 12.6% organic growth in revenue on a same-store basis over the second quarter of 2022. These results reflect both sequential and year-over-year improvement in volume trends, which have continued to gain momentum in 2023 from our ongoing efforts in caregiver hiring and retention strategies begun last year. We also benefitted from two statewide rate increases in our largest state market of Illinois, which went into effect on January 1, 2023, and April 1, 2023, respectively. For the second quarter of 2023, our home health revenues declined 10.9% on a same-store basis over the prior-year period as we continue to limit admissions from payers which have lower paying contracts, improving the overall profitability of our home health segment. While this segment is still a very small part of our overall business, we believe there are opportunities to continue to expand these operations both organically, by acquisition and by strategic partnerships. For our hospice business, which accounted for 19.3% of revenue, we continued to see modest sequential improvement in average daily census and median length of stay, which was 29 days in the second quarter, the highest it has been since before the pandemic. For the second quarter of 2023, hospice revenues were lower by 1.1% on a same-store basis compared with the same period last year, however, exclusive of the impact of sequestration our revenues would be essentially flat as compared to the prior year period.” said Allison.

Cash and Liquidity

As of June 30, 2023, the Company had cash of $84.2 million and bank debt of $81.4 million, with capacity and availability under its revolving credit facility of $409.3 million and $319.9 million, respectively. Net cash provided by operating activities was $41.6 million for the second quarter of 2023, inclusive of a net $1.0 million in ARPA funds utilization.

Looking Ahead

Allison continued, “We have generated very strong cash flow from operations in 2023, which has allowed us to repay debt and strengthen our balance sheet. As such, we are well positioned to continue making strategic investments in our business that will expand our operations and enhance our services across the continuum of care. In addition to organic growth opportunities, we remain focused on pursuing acquisitions that meet our desired operational and geographic profile and are accretive to our business. At the end of the second quarter, we announced a definitive agreement to acquire the entities comprising Tennessee Quality Care, a provider of home health, hospice, and private duty nursing services. Tennessee Quality Care serves an average daily census of approximately 1,800 patients through 17 locations covering a service area of over 50 counties in Tennessee, a certificate of need state for both home health and hospice services. This transaction is based on our acquisition strategy to leverage our strong personal care presence and add clinical services in select markets, especially where we have the opportunity to enter into value-based contracting models.

“We are very pleased with the trends in our business though the first half of the year and our ability to meet our key performance objectives. As always, we acknowledge the dedicated efforts of our caregivers who work hard every day to provide outstanding care for more patients and families. We are excited about the opportunities ahead for Addus in 2023, and we will continue to pursue a strategic direction that supports the patients in our care and delivers greater value to our shareholders,” added Allison.

Non-GAAP Financial Measures

The information provided in this release includes adjusted net income, adjusted EBITDA, and adjusted net income per diluted share, which are non-GAAP financial measures. The Company defines adjusted net income as net income before acquisition expenses, stock-based compensation expenses, and restructure and other non-recurring costs. The Company defines adjusted EBITDA as earnings before interest expense, other non-operating income, taxes, depreciation, amortization, acquisition expense, stock-based compensation expense, and restructure and other non-recurring costs. The Company defines adjusted net income per diluted share as net income per share, adjusted for acquisition expenses, stock-based compensation expense, and restructure and other non-recurring costs. The Company defines adjusted net service revenues as revenue adjusted for the closure of certain sites. The Company has provided, in the financial statement tables included in this press release, a reconciliation of adjusted net income to net

 

-MORE-


ADUS Announces Second Quarter 2023 Financial Results

Page 3

July 31, 2023

 

income, a reconciliation of adjusted EBITDA to net income, a reconciliation of adjusted diluted net income per share to net income per share, and a reconciliation of adjusted net service revenues to net service revenues, in each case, the most directly comparable GAAP measure. Management believes that adjusted net income, adjusted EBITDA, adjusted diluted net income per share, and adjusted net service revenues are useful to investors, management and others in evaluating the Company’s operating performance, to provide investors with insight and consistency in the Company’s financial reporting and to present a basis for comparison of the Company’s business operations among periods, and to facilitate comparison with the results of the Company’s peers.

Conference Call

Addus will host a conference call on Tuesday, August 1, 2023, at 9:00 a.m. Eastern time. To access the live call, dial (833) 629-0620 (international dial-in number is (412) 317-1805) and ask to join the Addus HomeCare earnings call. A telephonic replay of the conference call will be available through midnight on August 8, 2023, by dialing (877) 344-7529 (international dial-in number is (412) 317-0088) and entering pass code 2623612.

A live broadcast of Addus HomeCare’s conference call will be available under the Investor Relations section of the Company’s website: www.addus.com. An online replay will also be available on the Company’s website for one month, beginning approximately two hours following the conclusion of the live broadcast.

Forward-Looking Statements

Certain matters discussed in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may be identified by words such as “preliminary,” “continue,” “expect,” and similar expressions. These forward-looking statements are based on our current expectations and beliefs concerning future developments and their potential effect on us. Forward-looking statements involve a number of risks and uncertainties that may cause actual results to differ materially from those expressed or implied by such forward-looking statements, including discretionary determinations by government officials, the consummation and integration of acquisitions, transition to managed care providers, our ability to successfully execute our growth strategy, unexpected increases in SG&A and other expenses, expected benefits and unexpected costs of acquisitions and dispositions, management plans related to dispositions, the possibility that expected benefits may not materialize as expected, the failure of the business to perform as expected, changes in reimbursement, changes in government regulations, changes in Addus HomeCare’s relationships with referral sources, increased competition for Addus HomeCare’s services, changes in the interpretation of government regulations, the uncertainty regarding the outcome of discussions with managed care organizations, changes in tax rates, the impact of adverse weather, higher than anticipated costs, lower than anticipated cost savings, estimation inaccuracies in future revenues, margins, earnings and growth, whether any anticipated receipt of payments will materialize, any security breaches, cyber-attacks, loss of data or cybersecurity threats or incidents, and other risks set forth in the Risk Factors section in Addus HomeCare’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on February 28, 2023, which is available at www.sec.gov. The financial information described herein and the periods to which they relate are preliminary estimates that are subject to change and finalization. There is no assurance that the final amounts and adjustments will not differ materially from the amounts described above, or that additional adjustments will not be identified, the impact of which may be material. Addus HomeCare undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. In addition, these forward-looking statements necessarily depend upon assumptions, estimates and dates that may be incorrect or imprecise and involve known and unknown risks, uncertainties, and other factors. Accordingly, any forward-looking statements included in this press release do not purport to be predictions of future events or circumstances and may not be realized. (Unaudited tables and notes follow).

 

-MORE-


ADUS Announces Second Quarter 2023 Financial Results

Page 4

July 31, 2023

 

About Addus HomeCare

Addus HomeCare is a provider of home care services that primarily include personal care services that assist with activities of daily living, as well as hospice and home health services. Addus HomeCare’s consumers are primarily persons who, without these services, are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. Addus HomeCare’s payor clients include federal, state, and local governmental agencies, managed care organizations, commercial insurers, and private individuals. Addus HomeCare currently provides home care services to approximately 47,500 consumers through 204 locations across 22 states. For more information, please visit www.addus.com.

 

-MORE-


ADUS Announces Second Quarter 2023 Financial Results

Page 5

July 31, 2023

 

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

Condensed Consolidated Statements of Income

(amounts and shares in thousands, except per share data)

(Unaudited)

 

     For the Three Months     For the Six Months  
Income Statement Information:    Ended June 30,     Ended June 30,  
     2023     2022     2023     2022  

Net service revenues

   $ 259,980     $ 236,940     $ 511,579     $ 463,574  

Cost of service revenues

     177,662       161,342       350,846       317,790  
  

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

     82,318       75,598       160,733       145,784  
     31.7     31.9     31.4     31.4

General and administrative expenses

     57,397       55,095       113,757       108,247  

Depreciation and amortization

     3,382       3,609       6,829       7,130  
  

 

 

   

 

 

   

 

 

   

 

 

 

Total operating expenses

     60,779       58,704       120,586       115,377  
  

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

     21,539       16,894       40,147       30,407  

Total interest expense, net

     2,040       1,878       4,395       3,640  
  

 

 

   

 

 

   

 

 

   

 

 

 

Income before income taxes

     19,499       15,016       35,752       26,767  

Income tax expense

     4,647       3,766       8,225       7,047  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income

   $ 14,852     $ 11,250     $ 27,527     $ 19,720  
  

 

 

   

 

 

   

 

 

   

 

 

 

Net income per diluted share:

   $ 0.91     $ 0.70     $ 1.69     $ 1.22  
  

 

 

   

 

 

   

 

 

   

 

 

 

Weighted average number of common shares outstanding:

        

Diluted

     16,283       16,131       16,304       16,113  
     For the Three Months     For the Six Months  
Cash Flow Information:    Ended June 30,     Ended June 30,  
     2023     2022     2023     2022  

Net cash provided by (used in) operating activities

   $ 41,614     $ 56,519     $ 60,413     $ 62,502  

Net cash (used in) investing activities

     (969     (434     (2,711     (86,028

Net cash (used in) financing activities

     (30,000     (59,931     (53,475     (24,452
  

 

 

   

 

 

   

 

 

   

 

 

 

Net change in cash

     10,645       (3,846     4,227       (47,978

Cash at the beginning of the period

     73,543       124,763       79,961       168,895  
  

 

 

   

 

 

   

 

 

   

 

 

 

Cash at the end of the period

   $ 84,188     $ 120,917     $ 84,188     $ 120,917  
  

 

 

   

 

 

   

 

 

   

 

 

 

 

-MORE-


ADUS Announces Second Quarter 2023 Financial Results

Page 6

July 31, 2023

 

Condensed Consolidated Balance Sheets

(Amounts in thousands)

(Unaudited)

 

     June 30,  
     2023      2022  

Assets

     

Current assets

     

Cash

   $ 84,188      $ 120,917  

Accounts receivable, net

     104,252        124,554  

Prepaid expenses and other current assets

     19,350        10,901  
  

 

 

    

 

 

 

Total current assets

     207,790        256,372  
  

 

 

    

 

 

 

Property and equipment, net

     19,607        17,733  
  

 

 

    

 

 

 

Other assets

     

Goodwill

     583,656        574,752  

Intangible assets, net

     68,859        74,464  

Operating lease assets

     48,472        41,207  
  

 

 

    

 

 

 

Total other assets

     700,987        690,423  
  

 

 

    

 

 

 

Total assets

   $ 928,384      $ 964,528  
  

 

 

    

 

 

 

Liabilities and stockholders’ equity

     

Current liabilities

     

Accounts payable

   $ 20,699      $ 21,346  

Accrued payroll

     47,795        39,432  

Accrued expenses

     31,966        27,352  

Operating lease liabilities - current portion

     11,334        10,702  

Government stimulus advance

     9,959        16,735  

Accrued workers compensation

     12,149        12,437  
  

 

 

    

 

 

 

Total current liabilities

     133,902        128,004  

Long-term debt, less current portion, net of debt issuance costs

     78,702        196,342  

Long-term lease liability, less current portion

     43,214        38,343  

Other long-term liabilities

     6,215        2,062  
  

 

 

    

 

 

 

Total long-term liabilities

     128,131        236,747  
  

 

 

    

 

 

 

Total liabilities

     262,033        364,751  
  

 

 

    

 

 

 

Total stockholders’ equity

     666,351        599,777  
  

 

 

    

 

 

 

Total liabilities and stockholders’ equity

   $ 928,384      $ 964,528  
  

 

 

    

 

 

 

 

-MORE-


ADUS Announces Second Quarter 2023 Financial Results

Page 7

July 31, 2023

 

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

Net Service Revenue by Segment

(Amounts in thousands)

(Unaudited)

 

     For the Three Months      For the Six Months  
     Ended June 30,      Ended June 30,  
     2023      2022      2023      2022  

Net Service Revenues by Segment

           

Personal Care

   $ 198,314      $ 174,330      $ 388,346      $ 343,962  

Hospice

     50,210        52,074        99,292        99,801  

Home Health

     11,456        10,536        23,941        19,811  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total Revenue

   $ 259,980      $ 236,940      $ 511,579      $ 463,574  
  

 

 

    

 

 

    

 

 

    

 

 

 

 

-MORE-


ADUS Announces Second Quarter 2023 Financial Results

Page 8

July 31, 2023

 

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

Key Statistical and Financial Data (Unaudited)

 

     For the Three Months     For the Six Months  
     Ended June 30,     Ended June 30,  
     2023     2022     2023     2022  

Personal Care

        

States served at period end

     —         —         21       21  

Locations at period end

     —         —         157       161  

Average billable census - same store

     39,003       37,501       38,611       37,041  

Average billable census - acquisitions

     96       —         96       —    

Average billable census total

     39,099       37,501       38,707       37,041  

Billable hours (in thousands)

     7,682       7,373       15,274       14,474  

Average billable hours per census per month

     65.3       65.2       65.6       64.8  

Billable hours per business day

     118,177       113,426       117,491       112,198  

Revenues per billable hour

   $ 25.57     $ 23.58     $ 25.27     $ 23.61  

Organic growth

        

- Revenue

     12.6     2.5     11.7     1.7

Hospice

        

Locations served at period end

     —         —         34       33  

Admissions

     3,076       3,281       6,400       6,596  

Average daily census

     3,225       3,333       3,210       3,323  

Average discharge length of stay

     94.4       83.8       90.9       84.0  

Patient days

     293,502       303,289       581,053       578,777  

Revenue per patient day

   $ 174.32     $ 171.70     $ 175.26     $ 172.43  

Organic growth

        

- Revenue

     (1.1 ) %      2.5     0.5     3.4

- Average daily census

     (3.2 ) %      6.1     1.4     6.6

Home Health

        

Locations served at period end

     —         —         13       12  

New Admissions

     3,439       3,351       7,332       6,687  

Recertifications

     1,595       1,409       3,144       2,725  

Total Volume

     5,034       4,760       10,476       9,412  

Visits

     68,293       68,452       146,121       133,665  

Organic growth

        

- Revenue

     (10.9 ) %      24.6     0.7     12.6

- New admissions

     (17.5 ) %      25.2     (10.5 )%      13.9

- Volume

     (11.8 ) %      20.6     (10.9 )%      16.5

Percentage of Revenues by Payor:

        

Personal Care

        

State, local and other governmental programs

     50.6     49.0     50.4     49.2

Managed care organizations

     46.0       46.2       46.1       45.9  

Private duty

     2.2       2.7       2.2       2.7  

Commercial

     0.8       1.2       0.9       1.2  

Other

     0.4     0.9     0.4     1.0

Hospice

        

Medicare

     90.7     90.5     90.8     90.8

Commercial

     5.4       5.2       5.3       5.0  

Managed care organizations

     3.1       3.8       3.2       3.7  

Other

     0.8     0.5     0.7     0.5

Home Health

        

Medicare

     76.1     72.1     75.1     72.7

Managed care organizations

     19.6       21.5       20.0       21.0  

Commercial

     3.8       6.2       4.5       6.1  

Other

     0.5     0.2     0.4     0.2

 

-MORE-


ADUS Announces Second Quarter 2023 Financial Results

Page 9

July 31, 2023

 

ADDUS HOMECARE CORPORATION AND SUBSIDIARIES

Reconciliation of Non-GAAP Financial Measures

(Amounts in thousands, except per share data)

(Unaudited) (1)

 

     For the Three Months     For the Six Months  
     Ended June 30,     Ended June 30,  
     2023     2022     2023     2022  

Reconciliation of Adjusted EBITDA to Net Income: (1)

        

Net income

   $ 14,852     $ 11,250     $ 27,527     $ 19,720  

Interest expense, net

     2,040       1,878       4,395       3,640  

(Gain) Loss on sale of assets

     (3     (2     (3     (2

Income tax expense

     4,647       3,766       8,225       7,047  

Depreciation and amortization

     3,382       3,609       6,829       7,130  

Impact of retroactive New York rate increase

     (1,090     —         (868     —    

Acquisition expenses

     1,782       1,831       3,029       4,624  

Stock-based compensation expense

     2,613       2,680       5,259       5,165  

Restructure and other non-recurring costs

     75       89       170       186  
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted EBITDA

   $ 28,298     $ 25,101     $ 54,563     $ 47,510  
  

 

 

   

 

 

   

 

 

   

 

 

 

Reconciliation of Adjusted Net Income to Net Income: (2)

        

Net income

   $ 14,852     $ 11,250     $ 27,527     $ 19,720  

(Gain) Loss on sale of assets, net of tax

     (2     (1     (2     (1

Impact of retroactive New York rate increase, net of tax

     (830     —         (668     —    

Acquisition expenses, net of tax

     1,357       1,394       2,332       3,407  

Stock-based compensation expense, net of tax

     1,976       2,013       4,048       3,804  

Restructure and other non-recurring costs, net of tax

     57       66       131       137  
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted Net Income

   $ 17,410     $ 14,722     $ 33,368     $ 27,067  
  

 

 

   

 

 

   

 

 

   

 

 

 

Reconciliation of Net Income per Diluted Share to Adjusted Net Income per Diluted Share: (3)

 

   

Net income per diluted share

   $ 0.91     $ 0.70     $ 1.69     $ 1.22  

Impact of retroactive New York rate increase per diluted share

     (0.05     —         (0.04     —    

Acquisition expenses per diluted share

     0.08       0.08       0.14       0.21  

Restructure and other non-recurring costs per diluted share

     —         —         0.01       0.01  

Stock-based compensation expense per diluted share

     0.13       0.13       0.25       0.24  
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted net income per diluted share

   $ 1.07     $ 0.91     $ 2.05     $ 1.68  
  

 

 

   

 

 

   

 

 

   

 

 

 

Reconciliation of Net Service Revenues to Adjusted Net Service Revenues: (4)

 

   

Net service revenues

   $ 259,980     $ 236,940     $ 511,579     $ 463,574  

Revenues associated with the closure of certain sites

     —         (390     —         (843
  

 

 

   

 

 

   

 

 

   

 

 

 

Adjusted net service revenues

   $ 259,980     $ 236,550     $ 511,579     $ 462,731  
  

 

 

   

 

 

   

 

 

   

 

 

 

 

-MORE-


ADUS Announces Second Quarter 2023 Financial Results

Page 10

July 31, 2023

 

Footnotes:

 

(1)

We define Adjusted EBITDA as earnings before interest expense, other non-operating income, taxes, depreciation, amortization, acquisition expenses, stock-based compensation expense, restructure expenses and other non-recurring costs and loss on the sale of assets and retroactive rate increases from New York. Adjusted EBITDA is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.

(2)

We define Adjusted Net Income as net income before acquisition expenses, stock-based compensation expense, restructure and other non-recurring costs and gain or loss on the sale of assets and retroactive rate increases from New York. Adjusted Net Income is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.

(3)

We define Adjusted diluted earnings per share as earnings per share, adjusted for acquisition expenses, stock-based compensation expense and restructure and other non-recurring costs and loss on the sale of asset and retroactive rate increases from New York. Adjusted diluted earnings per share is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.

(4)

We define Adjusted net service revenues as revenue adjusted for the closure of certain sites. Adjusted net service revenues is a performance measure used by management that is not calculated in accordance with generally accepted accounting principles in the United States (GAAP). It should not be considered in isolation or as a substitute for net income, operating income or any other measure of financial performance calculated in accordance with GAAP.

 

-END-

EX-101.SCH 3 adus-20230731.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 4 adus-20230731_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Entity Registrant Name Entity Registrant Name Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 5 adus-20230731_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 g501240g0731213629235.jpg GRAPHIC begin 644 g501240g0731213629235.jpg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end XML 7 R1.htm IDEA: XBRL DOCUMENT v3.23.2
Document and Entity Information
Jul. 31, 2023
Cover [Abstract]  
Entity Registrant Name Addus HomeCare Corp
Amendment Flag false
Entity Central Index Key 0001468328
Document Type 8-K
Document Period End Date Jul. 31, 2023
Entity Incorporation State Country Code DE
Entity File Number 001-34504
Entity Tax Identification Number 20-5340172
Entity Address, Address Line One 6303 Cowboys Way
Entity Address, Address Line Two Suite 600
Entity Address, City or Town Frisco
Entity Address, State or Province TX
Entity Address, Postal Zip Code 75034
City Area Code (469)
Local Phone Number 535-8200
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.001 par value per share
Trading Symbol ADUS
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
XML 8 d501240d8k_htm.xml IDEA: XBRL DOCUMENT 0001468328 2023-07-31 2023-07-31 Addus HomeCare Corp false 0001468328 8-K 2023-07-31 DE 001-34504 20-5340172 6303 Cowboys Way Suite 600 Frisco TX 75034 (469) 535-8200 false false false false Common Stock, $0.001 par value per share ADUS NASDAQ false EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( /F$_U8'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " #YA/]6F914/>\ K @ $0 &1O8U!R;W!S+V-O&ULS9+/ M3L,P#(=?!>7>.FT%B*C+91,GD)"8!.(6)=X6K?FCQ*C=V].6K1."!^ 8^Y?/ MGR6W.@H=$KZD$#&1Q7PSN,YGH>.*'8BB ,CZ@$[EFC MVB/4G-^!0U)&D8()6,2%R&1KM- )%85TQAN]X.-GZF:8T8 =.O24H2HK8'*: M&$]#U\(5,,$(D\O?!30+<:[^B9T[P,[)(=LEU?=]V3=S;MRA@O?GI]=YW<+Z M3,IK'']E*^@4<<4ND]^:]6;[R&3-ZZ;@]T53;6LNF@=QRS\FUQ]^5V$7C-W9 M?VQ\$90M_+H+^0502P,$% @ ^83_5IE&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R M> +]O6N[!3+ MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,! M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2 MBW A(5M>5 TR M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$ MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH] M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2.FJW"$2M"/F(9 M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+ MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+ M.7\N?<^E[[GT/:'2MSAD6R4)RU3393>* M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.WF)&Y M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_# M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0 MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYNTB42%(JP# 4A M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.' MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_ M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]! MU4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04 M" #YA/]6)'7__UT$ J$0 & 'AL+W=OPC,_K1SI'KR2&.R'?5,28)OLD3M7(BK3.[FQ;!1%+J+H1&4OA ME[60"=70E!M;99+1L A*8MMSG)Z=4)Y:XV%Q;R['0Y'KF*=L+HG*DX3*PSV+ MQ6YDN=;[C1>^B;2Y88^'&=VP!=/?LKF$EEVIA#QAJ>(B)9*M1];$O;OWNB:@ M>.(WSG;JY)J8KJR$>#.-63BR'$/$8A9H(T'A:\NF+(Z-$G#\?12UJG>:P-/K M=_6GHO/0F155;"KB5Q[J:&0-+!*R-Z9 .\8X!7JZ7@HQ8Y(\S2HF8NBJT4T MP/'49&6A)?S*(4Z/'T20PR!K0M.0/*::ZP.9I66V8=2&MH:7F$?MX"AX7PIZ M9P1_R>,;XKM7Q',\_]_A-K!5@%X%Z!5Z_AF]J=@R2?Z'Q:QHKAG!T*X[N):,T M!1))8ZBPD.W))W9H(L*5',=Q.[V![PT0K%Z%U4/%JNI?'K+&G.'A@^M/"$2_ M@NA?!C%GD@LS"T,"<[F1!U>JYE[;Y!M4:(-+TC9+ RA'(0M+( L-<%"@.>02 M4BK"1E)<^.$1H;NMZ&XOH7OB,2//>;)BL@D$UX!JNO8[7:>#\+A.;:;.)41+ MNB>S$%+*USPH!^T\7XNDYUQW_8[C]CV,\,3NW4L(P6W "M75^P7Y#,^1KVEC M*ELD>[[C0QGL5N*@R"L]8)RUZ[NH:>.]7 M@%/3$I(LQ:YYU<3EGB17@<#(:LMW<<_^+UDY7P%M+L66IT%SCG'-Y>\86KT* MN!!1?XL=.[_0E# MJ1<$%_?QSR* 49E'(L6,K46DZW>O!QY>[?4ZX.)^_2JYUBR%H4F2/#V:FFJD MPH7:-A1N;?XN[MP+$?. :YYNR!+7W>[A1SXM=6P(K><#* M/05LO6#K^G6];LY?BUXK6>WY'F[0_R.;*94#62L@+ML*>++%;W%F%N323#_7 M6Y$EUW'C]&L1,3TL=B+LBWSLWL+23C$JRI7'.2 8]51%LK3'BVOT]W*Z7 MDH:F\A:'9"4:ZZY%8/+P;8&1U&[OX+;4[).3K_D7X0LU;U0D9FL0%H75Q&C,(T, _ [VLA]'O#G*^KOT?&_P!02P,$% M @ ^83_5I^@&_"Q @ X@P T !X;"]S='EL97,N>&ULW5=M:]LP$/XK M0C]@;F)JXI$8MD!AL(U"\V%?E5AV!'KQ9+ES^NNGLVPG:75EW8>QS:')W3VZ MNT=W)YFN6W>2_.'(N2.]DKK=T*-SS?LD:0]'KEC[SC1<>Z0R5C'G55LG;6,Y M*UMP4C)9WMQDB6)"TV*M.W6G7$L.IM-N0V]H4JPKH\^6E :#7\H4)X],;NB6 M2;&W8EC+E)"G8%Z"X6"DL<1Y*GQ#%V!IGP*\"!JP'.,HH8T%8Q(RA._]N/P9 M,&FM5X64,\$E#89BW3#GN-5W7AD6#\87$!GEW:GQ#&O+3HOE+3T[##\^R=[8 MDMLYS8).IF(M>05TK*B/\.M,DP#HG%%>* 6KC68#A\EC%'S8 Y?R 5KXK;J* MW5B'_2^FO-CT1=X=-8T\O1!BEHK'O;^RPF+-9O\R-%8\>2SP:0)P:?EA6;/CO9NFJ:]PSLM_D/.?K7/--;=,7I+VH_\W5_DMC)/Q]%PZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<&%Y_J?]K-#]! SCMHHB*]1GA?H$KQBR'3Y8GKA/ M[I_X3O,\3;,,J^AV&V6PQ>J69? 7CX9Q P\L#V1Z6ZWQ;N,3\OH<8#U];4*P MG>*3B.T4KS4@\;J!1Y['NXWE 0^L"]CL0/YX'IBIN$^:0ERHY M_U=3_ 102P,$% @ ^83_5I>*NQS $P( L !?3T\ M$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:(7->=I3W;+T]!;X"O.DQQ0FE(2S,.\,W2?S+W\PPU1>5* M(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_'FR-9V87YTC'?8Q']>5=2(6NF9MYEJ6R!F_236P@R*2* MY U+2X3[+O,&@EXN1:T/9=1,92L88!.R '<(Y_A^[<#K3P&]'@!6^AC(,=D",Y1]XVXG\ M-/O4(VSV'T:$%'J6"V&%E+C?Z/F-:#R!+ ]=R_$)'0.M#,,SQ;;!<.AHQ$5V M9://8:Q#B'/Z3XRQJK"$52Q;#X&'' E<)S"D&IND53 >"CVN*!.L>@PL(:EU M&*ADMW,JI]=V<,TB]RI#FJ,,:&T'X:-:"Q4&L&]R( DNR94;4EWI>::W=Y-[ M2:AU[D&P]_ :C1W-CQ^W_ %02P,$% @ ^83_5B0>FZ*M ^ $ !H M !X;"]?+7_OR4Z?:!1W;J"V\R1&:P;*9,OL M[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2*+I!V#-DGNZ9HIP\_D-T==UI?#C] MLCCP#S"\7>BI160I2A4:Y$S":+8VP5+BRTR6HJ@R&8HJEG!:(.+)(&UI5GVP M3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L#!!0 ( /F$_U9ED'F2&0$ ,\# M 3 6T-O;G1E;G1?5'EP97-=+GAM;*V334[#,!"%KQ)E6R4N+%B@IAM@ M"UUP 6-/&JO^DV=:TMLS3MI*H!(5A4VL>-Z\SYZ7K-Z/$;#HG?78E!U1?!0" M50=.8ATB>*ZT(3E)_)JV(DJUDUL0]\OE@U#!$WBJ*'N4Z]4SM')OJ7CI>1M- M\$V9P&)9/(W"S&I*&:,U2A+7Q<'K'Y3J1*BY<]!@9R(N6%"*JX1<^1UPZGL[ M0$I&0[&1B5ZE8Y7HK4 Z6L!ZVN+*&4/;&@4ZJ+WCEAIC JFQ R!GZ]%T,4TF MGC",S[O9_,%F"LC*30H1.;$$?\>=(\G=560C2&2FKW@ALO7L^T%.6X.^D\ K @ $0 M @ &O 9&]C4')O<',O8V]R92YX;6Q02P$"% ,4 " #YA/]6F5R< M(Q & "<)P $P @ '- 0 >&PO=&AE;64O=&AE;64Q+GAM M;%!+ 0(4 Q0 ( /F$_U8D=?__700 "H1 8 " @0X( M !X;"]W;W)K&PO&PO7W)E;',O=V]R:V)O;VLN>&UL M+G)E;'-02P$"% ,4 " #YA/]699!YDAD! #/ P $P M@ &W$@ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 "0 ) #X" !% " ! end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.2 html 1 23 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.addus.com//20230731/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName - d501240d8k.htm 7 d501240d8k.htm adus-20230731.xsd adus-20230731_lab.xml adus-20230731_pre.xml d501240dex991.htm http://xbrl.sec.gov/dei/2022 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d501240d8k.htm": { "axisCustom": 0, "axisStandard": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2022": 23 }, "contextCount": 1, "dts": { "inline": { "local": [ "d501240d8k.htm" ] }, "labelLink": { "local": [ "adus-20230731_lab.xml" ] }, "presentationLink": { "local": [ "adus-20230731_pre.xml" ] }, "schema": { "local": [ "adus-20230731.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd" ] } }, "elementCount": 24, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 3, "total": 3 }, "keyCustom": 0, "keyStandard": 23, "memberCustom": 0, "memberStandard": 0, "nsprefix": "adus", "nsuri": "http://www.addus.com/20230731", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d501240d8k.htm", "contextRef": "duration_2023-07-31_to_2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "menuCat": "Cover", "order": "1", "role": "http://www.addus.com//20230731/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "p", "div", "div", "body", "html" ], "baseRef": "d501240d8k.htm", "contextRef": "duration_2023-07-31_to_2023-07-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.addus.com//20230731/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.addus.com//20230731/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.addus.com//20230731/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.addus.com//20230731/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.addus.com//20230731/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.addus.com//20230731/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.addus.com//20230731/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.addus.com//20230731/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.addus.com//20230731/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.addus.com//20230731/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.addus.com//20230731/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.addus.com//20230731/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.addus.com//20230731/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.addus.com//20230731/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.addus.com//20230731/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.addus.com//20230731/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.addus.com//20230731/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.addus.com//20230731/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security 12b Title", "terseLabel": "Security 12b Title" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.addus.com//20230731/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.addus.com//20230731/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.addus.com//20230731/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.addus.com//20230731/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.addus.com//20230731/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" } }, "version": "2.2" } ZIP 16 0001193125-23-199181-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-23-199181-xbrl.zip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end